Carlo La Vecchia

Last updated
Carlo La Vecchia
Born (1955-02-27) February 27, 1955 (age 69)
Milan, Italy
Nationality Italian
Alma mater University of Milan
Known forwork on risks in cancer and other chronic diseases
AwardsOrder of Merit of the Italian Republic, Commander
Scientific career
Fields Epidemiology
Institutions Mario Negri Institute for Pharmacological Research, University of Milan, International Prevention Research Institute

Carlo La Vecchia (born February 27, 1955) is an Italian epidemiologist. He is doing research on chronic diseases, where he contributed to the understanding of the risks related to diet, tobacco, oral contraceptive use and occupational or environmental exposure to toxic substances in cancer and other chronic diseases development.

Contents

Biography

La Vecchia was born in Milan, Italy, studied medicine at the University of Milan and received a Doctor of Medicine degree with honors in 1979, after which he has joined the Mario Negri Institute for Pharmacological Research in Milan.

From 1981 - 1983 he was a Research Fellow at the Department of Community Medicine and Medical Practice, University of Oxford, where he received a M.Sc. in Clinical Medicine (Epidemiology).

Going back to Milan he received an additional Diploma from the Post-Graduate School, Mario Negri Institute, where he took the position of Head, Laboratory of Epidemiology, in 1989. Meantime he had started working also for the University of Milan and was awarded Associate Professorship of Epidemiology at the Institute of Medical Statistics and Biometrics [1] also in 1989. After becoming a Visiting Lecturer in the Department of Epidemiology, Harvard School of Public Health, Boston, USA (1994–1995), La Vecchia became Adjunct Associate Professor of Epidemiology (1996 to 2001). As of 2002 he was Adjunct Professor of Medicine at the School of Medicine, Vanderbilt University, Nashville, USA. The Eastman Dental Institute, University College London, awarded him a Honorary Senior Lecturer in Oral Medicine(1996–2001). [2]

In 2007 Carlo La Vecchia was promoted Head, Department of Epidemiology at Mario Negri. [3] In the same year he became a Senior Fellow of the International Agency for Research on Cancer, Lyon, France (2007–2009). Since 2008 he also holds an Adjunct Professorship of Epidemiology at the University of Lausanne, [4] Switzerland. In 2009 he became co-founder of the International Prevention Research Institute, a research and consulting company based in Lyon, France.

Carlo La Vecchia is also a Registered Journalist in Milan (Elenco pubblicisti No. 52412). He is married to Eva Negri.

Scientific merits

La Vecchia's specific fields of research are Cancer epidemiology (case-control studies on cancers of the breast, female genital tract, digestive sites, urinary organs, lymphoreticular malignancies, etc.); epidemiological studies on the risk related to diet, tobacco, oral contraceptive use and occupational or environmental exposure to toxic substances; coordination of clinical trials; analysis of temporal trends and of geographical distribution of mortality from cancer, cardiovascular diseases, perinatal and other selected conditions.

He is very much interested in international collaboration why he was and still is member of the several international research consortia, e.g. the INHANCE – Head and neck cancer consortium (since 2004).

La Vecchia is a member of many advisory and/or research committees, both nationally and internationally, e.g. Member of the UICC - American Cancer Society Fellowship Committee (1991–95); Member of the "Steering Committee" of the international cooperative network of case-control of the SEARCH Programme of the International Agency for Research on Cancer, IARC/WHO (1989–1991); Member of the Executive Committee of the European Society for Human Reproduction (ESHRE) (1991–95); Member of the Steering Committee, Collaborative Group on Hormonal Factors and Breast Cancer, and Chief, Steering Committee, Collaborative Group of Hormonal Factors and Cervical Cancers, both Oxford and IARC; He was a Member of the Ethical Committee, Centro di Riferimento Oncologico, Aviano PN, Italy (1998–2000); Member of the Scientific Committee, Air Quality Project, Fondazione Lombardia Ambiente, Regione Lombardia (1998–2000) and Member of the CPMP Ad hoc Expert Group on Oral Contraceptives and Cardiovascular Risks, EMEA, London, 1998–2001. Carlo is a founding member of the International Academy of Oral Oncology. [5] La Vecchia has participated and chaired several Working Groups during IARC's Monograph programme, e.g. Monograph 51 on Coffee, Tea, Mate, Methylxanthines and Methylglyoxal, 1990; Monograph 72 on the Evaluation of Carcinogenic Risks to Human. Monographs 72 and Member Monographs 91 on Hormonal Contraception and Post-menopausal Hormonal Therapy, 1998 and 2005, and 95 on Alcohol, 2007. [6] He is a Member of the Scientific Review Committee of the UNDP/WHO/World Bank Human Reproduction Programme(since 2000) and a Member of the Scientific Committee, Foundation for the Advancement of the Mediterranean Diet, Barcelona, Spain (since 2002).

Carlo La Vecchia was editor of several scientific journals in his field, like the European Journal of Public Health (1993–2003) or the Journal of Epidemiology and Biostatistics (1996–2002). He currently is Associate Editor of the journals European Journal of Cancer Prevention and Cancer Letter. He also serves or was serving at the Editorial board of the following journals: Alimentazione e Prevenzione (since 2000); American Journal of Epidemiology (1991–97); Archives of Medical Science [7] (since 2007); Asian Pacific Journal of Cancer Prevention (since 2000); Cancer Causes and Control (1991–96); Current Cancer Therapy Reviews [8] (since 2005); Dermatology Research and Practice (since 2007); Digestive and Liver Disease (since 2001); Economia Politica del Farmaco (since 2004); European Journal of Cancer (1991–95); European Journal of Cancer Prevention (since 1991); European Journal of Clinical Nutrition (since 1996); European Journal of Nutrition (since 1998); In Scope Oncology & Haematology (since 2004); International Journal of Cancer (since 2000); Journal of Nephrology (since 1992); Maturitas (since 2008); Nutrition and Cancer (since 2000); Oncology (1994–1995); Open Cancer Journal [9] (since 2007); Oral Oncology (since 2003); Revisiones en Ginecologia y Obstetricia (since 2000); Revista Española de Nutrición Comunitaria (since 1996); Revue d'Epidémiologie et de Santé Publique (since 1991); Sozial und Praeventivmedizin (1990—2001); The Lancet, edizione italiana (2005–2008); Tumori [10] (since 1993).

Carlo La Vecchia has published more than 1750 scientific articles [11] and is an ISI highly cited researcher [12]

Awards

Related Research Articles

<span class="mw-page-title-main">Oral cancer</span> Cancer of the lining of the lips, mouth, or upper throat

Oral cancer, also known as mouth cancer, is a cancer of the lining of the lips, mouth, or upper throat. In the mouth, it most commonly starts as a painless white patch, that thickens, develops red patches, an ulcer, and continues to grow. When on the lips, it commonly looks like a persistent crusting ulcer that does not heal, and slowly grows. Other symptoms may include difficult or painful swallowing, new lumps or bumps in the neck, a swelling in the mouth, or a feeling of numbness in the mouth or lips.

The International Agency for Research on Cancer is an intergovernmental agency forming part of the World Health Organization of the United Nations. Its role is to conduct and coordinate research into the causes of cancer. It also collects and publishes surveillance data regarding the occurrence of cancer worldwide.

<span class="mw-page-title-main">Alcohol and cancer</span> Relationship between cancer and the consumption of alcohol

Alcohol and cancer have a complex relationship. Alcohol causes cancers of the oesophagus, liver, breast, colon, oral cavity, rectum, pharynx, and larynx, and probably causes cancers of the pancreas. Cancer risk, can occur even with light to moderate drinking. The more alcohol is consumed, the higher the cancer risk, and no amount can be considered completely safe. Alcoholic beverages were classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) in 1988. An estimated 3.6% of all cancer cases and 3.5% of cancer deaths worldwide are attributable to consumption of alcohol. 740,000 cases of cancer in 2020 or 4.1% of new cancer cases were attributed to alcohol.

The Nurses' Health Study is a series of prospective studies that examine epidemiology and the long-term effects of nutrition, hormones, environment, and nurses' work-life on health and disease development. The studies have been among the largest investigations into risk factors for major chronic diseases ever conducted. The Nurses' Health Studies have led to many insights on health and well-being, including cancer prevention, cardiovascular disease, and type 2 diabetes. They have included clinicians, epidemiologists, and statisticians at the Channing Laboratory, Harvard Medical School, Harvard School of Public Health, and several Harvard-affiliated hospitals, including Brigham and Women's Hospital, Dana–Farber Cancer Institute, Children's Hospital Boston, and Beth Israel Deaconess Medical Center.

<span class="mw-page-title-main">Jan-Åke Gustafsson</span> Swedish biochemist

Jan-Åke Gustafsson is a Swedish scientist and professor in Biology, Biochemistry and Medical Nutrition. When he decided to move to Houston, Texas, USA, in 2008, the State of Texas decided to give a major US $5.5 million research grant to the University of Houston, enabling the establishment of the Center of Nuclear Receptors and Cell Signaling under the leadership of Jan-Åke Gustafsson. The grant was announced at a February 5, 2009, press conference by Rick Perry, Governor of Texas and running for the Republican nomination for President of the United States in the 2012 presidential election.

<span class="mw-page-title-main">Dimethisterone</span> Chemical compound

Dimethisterone, formerly sold under the brand names Lutagan and Secrosteron among others, is a progestin medication which was used in birth control pills and in the treatment of gynecological disorders but is now no longer available. It was used both alone and in combination with an estrogen. It is taken by mouth.

<span class="mw-page-title-main">Peter Boyle (epidemiologist)</span> British epidemiologist (1951–2022)

Peter Boyle, FRSE FFPH FRCPS(Glas) FRCP(Edin) FMedSci, was a British epidemiologist. He conducted research on globalisation of cancer, where he showed the dramatic increase of cancer in low- and medium income countries.

Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.

Philippe Autier is a Belgian epidemiologist. He is doing research on cancer, where he contributed to the understanding of the role of UV exposure in cancer development.

Clement Adebamowo is a Nigerian medical researcher and academic. Born in Lagos, Nigeria, Adebamowo is currently Director For Global Health Cancer Research, and a professor of Epidemiology & Public Health, at the University of Maryland School of Medicine. He is known for his work in cancer epidemiology, nutrition epidemiology, and research ethics, particularly in low resource and under-served in Africa.

Centro Studi GISED is an Italian research association with legal personality registered with no. 2096/2004 at the R.E.A. Register in Bergamo (Italy). It is a non-profit association established in 2002, and it develops research and educational programs with the aim of improving scientific knowledge, assistance and transparent and specific information to the public with regard to the main dermatological diseases.

Kurt Hellmann was a Bavarian clinical pharmacologist best known for his discovery of the biologic activity of two important drugs: Razoxane and Dexrazoxane.

<span class="mw-page-title-main">Lorenzo Tomatis</span> Italian oncologist (1929–2007)

Lorenzo (Renzo) Tomatis was an Italian physician and experimental oncologist who researched carcinogenesis and its primary prevention

<span class="mw-page-title-main">Renato Talamini</span> Italian epidemiologist

Renato Talamini is an Italian Epidemiologist. He is known for his research on cancer etiology, to which he contributed by helping to define the role of tobacco, diet, viral infections, and other lifestyle factors in cancer development.

Elizabeth M. Ward is an American scientist and researcher for the American Cancer Society. She received her PhD in Epidemiology from the University of Pennsylvania. Ward serves as the National Vice President of Intramural Research for the American Cancer Society and Chair of the World Trade Center Health Program Scientific and Technical Advisory Committee. She has held many positions in various cancer research organizations including a position on the National Cancer Institute's Board of Scientific Counselors for Clinical Sciences and Epidemiology. In recognition for her prominent work in the medical research field, she has received two different awards: U.S. Public Health Service Meritorious Service Medal and the Calum S. Muir Memorial Award. Ward's work is heavily centered around "cancer disparities, cancer treatment and outcomes, cancer surveillance, occupational cancer and environmental cancer."

<span class="mw-page-title-main">Silvio Garattini</span>

Silvio Garattini is an Italian scientist, pharmacology research scientist, physician and professor in chemotherapy and pharmacology and director of the Mario Negri Institute for Pharmacological Research.

Cornelia "Neli" Ulrich is executive director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI), Jon M. and Karen Huntsman Presidential Professor in Cancer Research, and former Division Chief of Cancer Population Sciences in the Department of Population Health Sciences at the University of Utah. Ulrich oversees HCI's academic consortium of nearly 200 cancer research teams. She leads efforts to advance the impact of HCI's research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. Prior to joining HCI, she was the director and department head of preventive oncology at the National Center of Tumor Diseases (NCT) and German Cancer Research Center (DKFZ) in Heidelberg. During this time, she also held a Professorship at the DKFZ and University of Heidelberg. From 1993 until 2009, Ulrich was a Member of the Fred Hutchinson Cancer Research Center and Professor in Epidemiology at the University of Washington in Seattle.

Adele Chandler Green is an Australian epidemiological senior scientist at the QIMR Berghofer Medical Research Institute in Brisbane and is the institute's Head of Cancer and Population Studies Group.

Tommaso A. Dragani is an Italian genetic epidemiologist whose research is focused on understanding the genetic control of complex phenotypes.

<span class="mw-page-title-main">Elisabete Weiderpass</span> Brazilian cancer researcher

Elisabete Weiderpass-Vainio is a Brazilian cancer researcher who is Director of the International Agency for Research on Cancer, a part of the World Health Organization. Her research considers the epidemiology and prevention of cancer.

References

  1. ↑ La Vecchias entry at the homepage of the Institute
  2. ↑ short CV at UCL homepage Archived June 15, 2011, at the Wayback Machine
  3. ↑ Departmental homepage at Mario Negri Archived July 20, 2011, at the Wayback Machine
  4. ↑ La Vecchia at University of Lausanne homepage
  5. ↑ The International Academy of Oral Oncology Archived June 15, 2011, at the Wayback Machine
  6. ↑ List of Participants of the Monograph meeting Archived December 7, 2008, at the Wayback Machine
  7. ↑ Archives of Medical Science
  8. ↑ Current Cancer Therapy Reviews Archived June 16, 2010, at the Wayback Machine
  9. ↑ Open Cancer Journal Archived June 19, 2010, at the Wayback Machine
  10. ↑ Tumori Archived February 2, 2010, at the Wayback Machine
  11. ↑ vecchia,carlo&cmd=correctspelling Carlo La Vecchia's publications
  12. ↑ Description of La Vecchia at ISI [ dead link ]
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.